USANA Health Sciences (USNA) said Monday the clinical study for its skin treatment Celavive Resurfacing Serum showed statistically significant improvements in the users' skin appearance and was well tolerated by all subjects.
The clinical study, which was done over 12 weeks to assess the efficacy and tolerance of the product, included 33 women with mild to moderate skin concerns, the company said.
Price: 24.77, Change: +0.03, Percent Change: +0.12
免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。